Designed to process millions of tests per year, the Bio-AI platform builds on peer-reviewed research showing 94% sensitivity across four major cancers.ENGLEWOOD, N.J.--(BUSINESS WIRE)--SpotitEarly, an early cancer detection startup that uses AI and trained canines to identify cancer odor signatures in breath samples, today unveiled LUCID 2.0, the next generation of its Bio-AI Hybrid platform, more... The post AI Meets Olfaction: SpotitEarly Unve…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.